In case you didn't see what My was talking about re: investor Douglas Grindstaff, Lab Monkey on Reddit notes that Grindstaff replied to Max Lataillade's Leron post on LinkedIn:

Grindstaff wrote:

"The potential impact of CCR5 inhibition is significant for anyone with metastatic colorectal cancer and triple negative breast cancer as weak as hiv. Finally l, the true potential is beginning to be recognized. Cytodyn is one of our first vintage investments and we never lost faith in the science."

See My's posts for why Grindstaff is a big cheese.